Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Details)

v3.7.0.1
Shareholders' Equity (Details)
1 Months Ended 6 Months Ended
Sep. 04, 2015
Employees
shares
Jun. 01, 2015
shares
Apr. 24, 2017
shares
Sep. 30, 2016
USD ($)
shares
May 31, 2016
shares
Apr. 30, 2016
shares
Jun. 30, 2017
USD ($)
Jun. 30, 2016
USD ($)
shares
Shareholders' Equity (Textual)                
Stock based compensation | $             $ 1,238,168 $ 2,249,839
Vesting period term   24 months     12 months      
Chairman of the Board [Member]                
Shareholders' Equity (Textual)                
Shares of restricted common stock issued | shares   50,000            
Recognized total expense | $             135,000 135,000
Dr. Philip Frost and Steven Rubin [Member]                
Shareholders' Equity (Textual)                
Common stock issued, shares | shares         150,000      
Recognized total expense | $             29,500 75,000
2015 Equity Plan [Member]                
Shareholders' Equity (Textual)                
Shares of restricted common stock issued | shares       1,349,000   1,150,000    
Shares vest upon consummation of equity and/or debt financing | $       $ 5,000,000        
Stock based compensation | $             $ 970,067 $ 1,115,500
Common stock issued, shares | shares               100,000
Recognized total expense | $               $ 24,250
Stock award agreements [Member]                
Shareholders' Equity (Textual)                
Shares of restricted common stock issued | shares 450,000              
Stock based compensation | $               $ 604,440
Number of management employees | Employees 4              
Number of director | Employees 1              
Series A Preferred Stock [Member]                
Shareholders' Equity (Textual)                
Preferred stock converted shares | shares     100,100          
Aggregate shares of restricted common stock | shares     250,250